Video-based assessments of activities of daily living: generating real-world evidence in pediatric rare diseases

References

• Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–173. doi: 10.1038/s41431-019-0508-0
   PubMed Web of Science ®Google Scholar
• EURORDIS - Rare Diseases Europe. Information & support. What is a rare disease? [Internet]. [cited 2024 Apr 19]. Available from: https://www.eurordis.org/information-support/what-is-a-rare-disease/
   Google Scholar
• Atkins JC, Padgett CR. Living with a rare disease: psychosocial impacts for parents and family members – a systematic review. J Child Fam Stud. 2024;33:617–636. doi: 10.1007/s10826-024-02790-6
   Web of Science ®Google Scholar
• EURORDIS-Rare Diseases Europe. Juggling care and daily life: the balancing act of the rare disease community [Internet]. 2017 [cited 2024 Apr 27]. Available from: https://download2.eurordis.org/rbv/2017_05_09_Social%20survey%20leaflet%20final.pdf
   Google Scholar
• Witt S, Schuett K, Wiegand-Grefe S, et al. Living with a rare disease - experiences and needs in pediatric patients and their parents. Orphanet J Rare Dis. 2023;18(1):242. doi: 10.1186/s13023-023-02837-9 Cited: in: PMID: 37568186
   PubMed Web of Science ®Google Scholar
• Sandilands K, Williams A, Rylands AJ. Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet J Rare Dis. 2022;17:428. doi: 10.1186/s13023-022-02561-w
   PubMed Web of Science ®Google Scholar
• Belzer LT, Wright SM, Goodwin EJ, et al. Psychosocial considerations for the child with rare disease: a review with recommendations and calls to action. Children. 2022;9:933. doi: 10.3390/children9070933
   PubMedGoogle Scholar
• Valcárcel-Nazco C, Ramallo-Fariña Y, Linertová R, et al. Health-related quality of life and perceived burden of informal caregivers of patients with rare diseases in selected European Countries. Int J Environ Res Public Health. 2022;19:8208. doi: 10.3390/ijerph19138208 Cited: in: PMID: 35805867.
   PubMed Web of Science ®Google Scholar
• Morel T, Cano SJ. Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet J Rare Dis. 2017;12(1):171. doi: 10.1186/s13023-017-0718-x
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for Industry, Food and Drug Administration staff, and Other Stakeholders. [Internet]; 2022 [cited 2024 May 22]. Available from: https://www.fda.gov/media/159500/download
   Google Scholar
• Pashmdarfard M, Azad A. Assessment tools to evaluate activities of daily living (ADL) and instrumental activities of daily living (IADL) in older adults: A systematic review. Med J Islam Repub Iran. 2020;34:33. doi: 10.47176/mjiri.34.33 Cited: in: PMID: 32617272.
   PubMedGoogle Scholar
• Mlinac ME, Feng MC. Assessment of activities of daily living, self-care, and independence. Arch Clin Neuropsychol. 2016;31:506–516. doi: 10.1093/arclin/acw049
   PubMed Web of Science ®Google Scholar
• Phillips RL, Olds T, Boshoff K, Lane AE. Measuring activity and participation in children and adolescents with disabilities: a literature review of available instruments. Aust Occup Ther J. 2013;60(4):288–300. doi: 10.1111/1440-1630.12055 Cited: in: PMID: 23888979.
   PubMed Web of Science ®Google Scholar
• Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: reliability and validity of the pediatric quality of life inventory™ version 4.0 generic core scales in healthy and patient populations. Med care. 2001;39(8):800–812. doi: 10.1097/00005650-200108000-00006
   PubMed Web of Science ®Google Scholar
• Wille N, Badia X, Bonsel G, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19:875–886. doi: 10.1007/s11136-010-9648-y
   PubMed Web of Science ®Google Scholar
• Benjamin K, Vernon MK, Patrick DL, et al. Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an ISPOR COA emerging good practices task force report. Value Health. 2017;20(7):838–855. doi: 10.1016/j.jval.2017.05.015 Cited: in: PMID: 28712612
   PubMed Web of Science ®Google Scholar
• Hong YD, Villalonga-Olives E, Perfetto EM. Patient-reported outcomes in orphan drug labels approved by the US food and drug administration. Value Health. 2019;22:925–930. doi: 10.1016/j.jval.2019.03.010 Cited: in: PMID: 31426934.
   PubMed Web of Science ®Google Scholar
• Whittal A, Meregaglia M, Nicod E. The use of patient-reported outcome measures in rare diseases and implications for health technology assessment. Patient - Patient-Centered Outcomes Res. 2021;14:485–503. doi: 10.1007/s40271-020-00493-w
   Web of Science ®Google Scholar
• Greenberg KK, Schwartz AE, Kramer JM. Adoption of patient-reported outcome measures with youth with intellectual/developmental disabilities: Contextual influences and practice patterns. Child Care Health Dev. 2021;47:501–508. doi: 10.1111/cch.12862
   PubMed Web of Science ®Google Scholar
• Lenderking WR, Anatchkova M, Pokrzywinski R, et al. Measuring health-related quality of life in patients with rare disease. J Patient-Rep Outcomes. 2021;5(1):61. doi: 10.1186/s41687-021-00336-8 Cited: in: PMID: 34283357.
   PubMedGoogle Scholar
• Davies EH, Matthews C, Merlet A, et al. Time to see the difference: video capture for patient-centered clinical trials. PCOR [Internet]. 2022 [cited 2022 Apr 4];15(4):389–397. doi: 10.1007/s40271-021-00569-1
   Google Scholar
• Edemekong PF, Bomgaars DL, Sukumaran S, et al. Activities of daily living. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Sep 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470404/
   Google Scholar
• Rothuizen-Lindenschot M, Graff MJL, de Boer L, et al. Using PRPP-Assessment for measuring change in everyday activities by home-based videos: An exploratory case series study in children with multiple disabilities. Aust Occup Ther J. 2023;70(6):644–660. doi: 10.1111/1440-1630.12893
   PubMed Web of Science ®Google Scholar
• Barrios-Fernandez S, Gozalo M, Garcia-Gomez A, et al. A novel tool to assess basic activities of daily living in Spanish preschoolers. Children. 2021;8:496. doi: 10.3390/children8060496
   PubMedGoogle Scholar
• Brown V, Merikle E, Johnston K, et al. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. J Patient-Rep Outcomes. 2023;7(1):129. doi: 10.1186/s41687-023-00669-6 Cited: in: PMID: 38085412.
   PubMedGoogle Scholar
• Kay C, Audo I, Naujoks C, et al. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in retinitis pigmentosa and Leber congenital amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures. J Patient-Rep Outcomes. 2023;7(1):74. doi: 10.1186/s41687-023-00610-x Cited: in: PMID: 37466759.
   PubMedGoogle Scholar
• Giugliani R, Harmatz P, Lin S-P, et al. Assessing the impact of the five senses on quality of life in mucopolysaccharidoses. Orphanet J Rare Dis. 2020;15:97. doi: 10.1186/s13023-020-01368-x
   PubMed Web of Science ®Google Scholar
• Hildenbrand H, Wickstrom J, Parks R, et al. Characterizing upper limb function in the context of activities of daily living in CLN3 Disease. Am J Med Genet A. 2021;185:1399–1413. doi: 10.1002/ajmg.a.62114 Cited: in: PMID: 33559393.
   PubMed Web of Science ®Google Scholar
• Adams H, de BE, Mink JW, et al. Standardized assessment of behavior and adaptive living skills in juvenile neuronal ceroid lipofuscinosis. Dev Med Child Neurol. 2006;48(4):259–264. doi: 10.1017/S0012162206000570
   PubMed Web of Science ®Google Scholar
• Nevin SM, McGill BC, Kelada L, et al. The psychosocial impact of childhood dementia on children and their parents: a systematic review. Orphanet J Rare Dis. 2023;18(1):277. doi: 10.1186/s13023-023-02859-3
   PubMed Web of Science ®Google Scholar
• Wright D, Kenny A, Eley S, McKechanie AG, et al. Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description. J Neurodev Disord. 2022;14:34. doi: 10.1186/s11689-022-09437-x Cited: in: PMID: 35655128.
   PubMed Web of Science ®Google Scholar
• Barco TL, Gaetano LD, Santangelo E, et al. SYNGAP1-related developmental and epileptic encephalopathy: The impact on daily life. Epilepsy Behav [Internet]. 2022 [cited 2024 Feb 5];127. doi: 10.1016/j.yebeh.2021.108500 Cited: in: PMID: 34954508.
   PubMed Web of Science ®Google Scholar
• Nabbout R, Auvin S, Chiron C, et al. Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome. Epilepsy Behav. 2018;78:232–242. doi: 10.1016/j.yebeh.2017.08.029 Cited: in: PMID: 29108913.
   PubMed Web of Science ®Google Scholar
• Villas N, Meskis MA, Goodliffe S. Dravet syndrome: Characteristics, comorbidities, and caregiver concerns. Epilepsy Behav. 2017;74:81–86. doi: 10.1016/j.yebeh.2017.06.031
   PubMed Web of Science ®Google Scholar
• Porter KA, O’Neill C, Drake E, et al. Parent experiences of Sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment. Neurol Ther. 2020;10(1):197–212. doi: 10.1007/s40120-020-00226-z Cited: in: PMID: 33263924.
   PubMed Web of Science ®Google Scholar
• López-Bastida J, Peña-Longobardo LM, Aranda-Reneo I, et al. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12:141. doi: 10.1186/s13023-017-0695-0
   PubMed Web of Science ®Google Scholar
• Wibbeler E, Nickel M, Schwering C, et al. The unified batten disease rating scale (UBDRS): Validation and reliability in an independent CLN3 disease sample. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2022;38:62–65. doi: 10.1016/j.ejpn.2022.03.005 Cited: in: PMID: 35427884.
   PubMed Web of Science ®Google Scholar
• Connor-Ahmad S, Tjeertes J, Chladek M, et al. Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development. Orphanet J Rare Dis. 2023;18:156. doi: 10.1186/s13023-023-02729-y
   PubMed Web of Science ®Google Scholar
• James S, Ziviani J, Boyd R. A systematic review of activities of daily living measures for children and adolescents with cerebral palsy. Dev Med Child Neurol. 2014;56:233–244. doi: 10.1111/dmcn.12226
   PubMed Web of Science ®Google Scholar
• Sparrow SS. Vineland Adaptive Behavior Scales. Encycl Clin Neuropsychol [Internet]. Springer, New York, NY; 2011 [cited 2023 Dec 20]:2618–2621. Available from: https://link.springer.com/referenceworkentry/10.1007/978-0-387-79948-3_1602
   Google Scholar
• Young NL, Williams JI, Yoshida KK, et al. Measurement properties of the activities scale for kids. J Clin Epidemiol. 2000;53(2):125–137. doi: 10.1016/S0895-4356(99)00113-4
   PubMed Web of Science ®Google Scholar
• Porter KA, O’Neill C, Drake E, et al. Caregivers’ assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J Patient-Rep Outcomes. 2022;6:40. doi: 10.1186/s41687-022-00447-w Cited: in: PMID: 35467223.
   PubMedGoogle Scholar
• Penn-Edwards S. Visual evidence in qualitative research: the role of videorecording. Qual Rep. 2004;9:266–277. doi: 10.46743/2160-3715/2004.1928
   Google Scholar
• McConachie H, Parr JR, Glod M, et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. Health Technol Assess Winch Engl. 2015;19:1–506. doi: 10.3310/hta19410 Cited: in: PMID: 26065374.
   PubMed Web of Science ®Google Scholar
• Pesch MH, Lumeng JC. Methodological considerations for observational coding of eating and feeding behaviors in children and their families. Int J Behav Nutr Phys Act. 2017;14:170. doi: 10.1186/s12966-017-0619-3 Cited: in: PMID: 29246234.
   PubMed Web of Science ®Google Scholar
• Grobe-Einsler M, Taheri Amin A, Faber J, et al. Development of SARAhome, a new video-based tool for the assessment of ataxia at home. Mov Disord. 2021;36(5):1242–1246. doi: 10.1002/mds.28478
   PubMed Web of Science ®Google Scholar
• Sibley KG, Girges C, Hoque E, Foltynie T. Video-based analyses of Parkinson’s disease severity: a brief review. J Park Dis. 2021;11(s1):S83–S93. doi: 10.3233/JPD-202402 Cited: in: PMID: 33682727.
   Google Scholar
• Fyfe S, Downs J, McIlroy O, et al. Development of a video-based evaluation tool in rett syndrome. J Autism Dev Disord. 2007;37(9):1636–1646. doi: 10.1007/s10803-006-0293-9
   PubMed Web of Science ®Google Scholar
• Contesse MG, Sapp ATL, Apkon SD, et al. Reliability and construct validity of the Duchenne Video Assessment. Muscle Nerve. 2021;64:180–189. doi: 10.1002/mus.27335
   PubMed Web of Science ®Google Scholar
• White MK, Leffler M, Rychlec K, et al. Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD). Qual Life Res. 2019;28:2979–2988. doi: 10.1007/s11136-019-02245-2
   PubMed Web of Science ®Google Scholar
• Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. PLOS ONE. [cited 2023 Feb 1]. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0266845
   Web of Science ®Google Scholar
• Phillips D, Griffin D, Przybylski T, et al. Development and validation of a modified performance-oriented mobility assessment tool for assessing mobility in children with hypophosphatasia. J Pediatr Rehabil Med. 2018;11(3):187–192. doi: 10.3233/PRM-170523 Cited: in: PMID: 30223404.
   PubMedGoogle Scholar
• Stenum J, Cherry-Allen KM, Pyles CO, et al. Applications of pose estimation in human health and performance across the lifespan. Sensors. 2021;21(21):7315. doi: 10.3390/s21217315
   PubMed Web of Science ®Google Scholar
• Cao Z, Hidalgo G, Simon T, Wei S-E, Sheikh Y. OpenPose: realtime multi-person 2d pose estimation using part affinity fields. IEEE Trans Pattern Anal Mach Intell. 2021;43(1):172–186. doi: 10.1109/TPAMI.2019.2929257 Cited: in: PMID: 31331883.
   PubMed Web of Science ®Google Scholar
• Leo M, Bernava GM, Carcagnì P, Distante C. Video-based automatic baby motion analysis for early neurological disorder diagnosis: state of the art and future directions. Sensors. 2022;22:866. doi: 10.3390/s22030866 Cited: in: PMID: 35161612.
   PubMed Web of Science ®Google Scholar
• Adams RJ, Lichter MD, Krepkovich ET, et al. Assessing upper extremity motor function in practice of virtual activities of daily living. IEEE Trans Neural Syst Rehabil Eng. 2015;23:287–296. doi: 10.1109/TNSRE.2014.2360149
   PubMed Web of Science ®Google Scholar
• Novotny M, Tykalova T, Ruzickova H, et al. Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease. NPJ Digit Med. 2022;5(1):1–8. doi: 10.1038/s41746-022-00642-5
   PubMed Web of Science ®Google Scholar
• Ng K-D, Mehdizadeh S, Iaboni A, et al. Measuring gait variables using computer vision to assess mobility and fall risk in older adults with dementia. IEEE J Transl Eng Health Med. 2020;8:1–9. doi: 10.1109/JTEHM.2020.2998326
   Google Scholar
• Ferrer-Mallol E, Matthews C, Stoodley M, et al. Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases. Front Pharmacol [Internet]. 2022 [cited 2022 Dec 15];13. doi: 10.3389/fphar.2022.916714
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (US). Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments [Internet]. 2022. Available from: https://www.fda.gov/media/159500/download
   Google Scholar
• Edgar CJ, Bush E(, Adams HR, et al. Recommendations on the selection, development, and modification of performance outcome assessments: a good practices report of an ISPOR task force. Value Health. 2023;26(7):959–967. doi: 10.1016/j.jval.2023.05.003
   PubMed Web of Science ®Google Scholar
• Manta C, Patrick-Lake B, Goldsack JC. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit Biomark. 2020;4(3):69–77. doi: 10.1159/000509725 Cited: in: PMID: 33083687
   PubMedGoogle Scholar
• Goldsack JC, Coravos A, Bakker JP, et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for biometric monitoring technologies (BioMets). NPJ Digit Med. 2020;3(1):1–15. doi: 10.1038/s41746-020-0260-4
   PubMed Web of Science ®Google Scholar
• Digital health technologies for remote data acquisition in clinical investigations guidance for industry, investigators, and other stakeholders [Internet]. 2023. Available from: https://www.fda.gov/media/155022/download
   Google Scholar
• Colloud S, Metcalfe T, Askin S, Belachew S, Ammann J, Bos E, Kilchenmann T, Strijbos P, Eggenspieler D, Servais L, et al. Evolving regulatory perspectives on digital health technologies for medicinal product development. NPJ Digit Med. 2023;6(1):56. doi: 10.1038/s41746-023-00790-2 Cited: in: PMID: 36991116.
   PubMed Web of Science ®Google Scholar
• Jessie PB, Barge R, Centra J, et al. V3+: An extension to the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies [Internet]. Digital medicine society. 2024 [cited 2024 Apr 26]. Available from: https://datacc.dimesociety.org/v3/extending-v3/
   Google Scholar
• FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016 [cited 2024 Feb 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK326791/
   Google Scholar
• 74th Cellular, Tissue, and Gene Therapies Advisory Committee. US Food and Drug Administration [Internet]. 2023 [cited 2024 Feb 8]. Available from: https://www.youtube.com/watch?v=k33d4h-CpGU
   Google Scholar
• Hong D, Avorn J, Wyss R, et al. Characteristics of patients receiving novel muscular dystrophy drugs in trials vs routine care. JAMA Netw Open. 2024;7:e2353094. doi: 10.1001/jamanetworkopen.2023.53094
   PubMed Web of Science ®Google Scholar